These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 6683359

  • 1. The effects of dose and duration of chronic pimozide administration on dopamine receptor supersensitivity.
    Dewey KJ, Fibiger HC.
    Naunyn Schmiedebergs Arch Pharmacol; 1983 May; 322(4):261-70. PubMed ID: 6683359
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat.
    Pittman KJ, Jakubovic A, Fibiger HC.
    Psychopharmacology (Berl); 1984 May; 82(4):371-7. PubMed ID: 6427831
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.
    Fleminger S, Rupniak NM, Hall MD, Jenner P, Marsden CD.
    Biochem Pharmacol; 1983 Oct 01; 32(19):2921-7. PubMed ID: 6138043
    [Abstract] [Full Text] [Related]

  • 6. Effects of dopamine supersensitivity on lateral hypothalamic self-stimulation in rats.
    Ettenberg A, Milner PM.
    Pharmacol Biochem Behav; 1977 Dec 01; 7(6):507-14. PubMed ID: 563603
    [Abstract] [Full Text] [Related]

  • 7. Behavioral and biochemical aspects of neuroleptic-induced dopaminergic supersensitivity: studies with chronic clozapine and haloperidol.
    Seeger TF, Thal L, Gardner EL.
    Psychopharmacology (Berl); 1982 Dec 01; 76(2):182-7. PubMed ID: 6805029
    [Abstract] [Full Text] [Related]

  • 8. Conditioned stereotypy: behavioral specification of the UCS and pharmacological investigation of the neural change.
    Hiroi N, White NM.
    Pharmacol Biochem Behav; 1989 Jan 01; 32(1):249-58. PubMed ID: 2543991
    [Abstract] [Full Text] [Related]

  • 9. Long-lasting dopamine receptor up-regulation in amphetamine-treated rats following amphetamine neurotoxicity.
    Fields JZ, Wichlinski L, Drucker GE, Engh K, Gordon JH.
    Pharmacol Biochem Behav; 1991 Dec 01; 40(4):881-6. PubMed ID: 1816575
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dopamine receptor sensitivity after chronic dopamine agonists. Striatal 3H-spiroperidol binding in mice after chronic administration of high doses of apomorphine, N-n-propylnorapomorphine and dextroamphetamine.
    Riffee WH, Wilcox RE, Vaughn DM, Smith RV.
    Psychopharmacology (Berl); 1982 Dec 01; 77(2):146-9. PubMed ID: 6812131
    [Abstract] [Full Text] [Related]

  • 12. Analysis of the difference in the behavioral effects of apomorphine in C57BL/6 and DBA/2 mice.
    Vetulani J, Sansone M, Oliverio A.
    Pharmacol Biochem Behav; 1982 Nov 01; 17(5):967-71. PubMed ID: 6891071
    [Abstract] [Full Text] [Related]

  • 13. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
    Staunton DA, Magistretti PJ, Shoemaker WJ, Deyo SN, Bloom FE.
    Brain Res; 1982 Jan 28; 232(2):401-12. PubMed ID: 6322915
    [Abstract] [Full Text] [Related]

  • 14. The effect of chronic bromocriptine and L-dopa on spiperone binding and apomorphine-induced stereotypy.
    Globus M, Bannet J, Lerer B, Belmaker RH.
    Psychopharmacology (Berl); 1982 Jan 28; 78(1):81-4. PubMed ID: 6815701
    [Abstract] [Full Text] [Related]

  • 15. Cerebral dopamine function in rats following withdrawal from one year of continuous neuroleptic administration.
    Clow A, Theodorou A, Jenner P, Marsden CD.
    Eur J Pharmacol; 1980 May 02; 63(2-3):145-57. PubMed ID: 6103814
    [Abstract] [Full Text] [Related]

  • 16. Thioridazine chronic administration: a behavioural and autoradiographic study.
    Calzà L, Giardino L, Piazza PV, Amato G.
    Neurosci Lett; 1990 Feb 05; 109(1-2):206-11. PubMed ID: 2314636
    [Abstract] [Full Text] [Related]

  • 17. Enhanced striatal 3H-spiroperidol binding induced by chronic haloperidol treatment inhibited by peptides administered during the withdrawal phase.
    Bhargava HN.
    Life Sci; 1984 Feb 27; 34(9):873-9. PubMed ID: 6142397
    [Abstract] [Full Text] [Related]

  • 18. The effect of dopamine receptor agonist treatment on haloperidol-induced supersensitivity in mice.
    Fayle P, Jackson DM, Jenkins OF, Lafferty PA.
    Pharmacol Biochem Behav; 1985 Nov 27; 23(5):715-20. PubMed ID: 4080755
    [Abstract] [Full Text] [Related]

  • 19. Permanent haloperidol-induced dopamine receptor up-regulation in the ovariectomized rat.
    Fields JZ, Gordon JH.
    Brain Res Bull; 1991 Apr 27; 26(4):549-52. PubMed ID: 1831063
    [Abstract] [Full Text] [Related]

  • 20. Cyclo (Leu-Gly) attenuates the striatal dopaminergic supersensitivity induced by chronic morphine.
    Lee JM, DeLeon-Jones F, Fields JZ, Ritzmann RF.
    Alcohol Drug Res; 1987 Apr 27; 7(1):1-10. PubMed ID: 2431697
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.